terbutaline has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, Y | 1 |
| Inagaki, T | 1 |
| Morioka, S | 1 |
| Kusano, E | 1 |
| Ohmagari, N | 1 |
| Matheny, M | 1 |
| Maleque, N | 1 |
| Channell, N | 1 |
| Eisch, AR | 1 |
| Auld, SC | 1 |
| Banerji, A | 1 |
| Druey, KM | 1 |
1 review available for terbutaline and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech).
Topics: BNT162 Vaccine; Capillary Leak Syndrome; COVID-19; COVID-19 Vaccines; Humans; Male; Terbutaline | 2023 |
1 other study available for terbutaline and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.
Topics: Aged; Capillary Leak Syndrome; Cardiovascular Agents; COVID-19; COVID-19 Vaccines; Disease Progressi | 2021 |